Start cervical cancer screening on Saba February 7th 2022, a pilot for population screening for cervical cancer will start on Saba. All women between 30 and 60 years, will be invited to participate in the coming three years.
Over half a million positive COVID-19 tests, more hospital admissions Last week*, 530,015 positive COVID-19 tests were reported to RIVM**. That is an increase of 45% compared to the week before that. The number of new hospital admissions rose by 11% in the past week. ICU admissions rose by 18%.
Dutch experts on climate change adaptation join forces Fourteen Dutch knowledge institutes have joined forces to provide practical, demand-driven policy advice based on climate change adaptation.
Substances of very high concern hamper recycling Substances of very high concern (SVHC) can hamper the safe recycling of waste streams in the Netherlands. These substances occur in a wide range of waste streams.
Chemical legislation REACHes out to bio-based economy European REACH regulation on chemicals can provide benefits to companies that make or import bio-based substances.
Greenhouse Emission model suited for the authorisation of plant protection products Residues of plant protection products used in greenhouses may enter surface water upon discharge of nutrient solution and affect surface water organisms.
Increase in number of additives in tobacco products A total of 673 different types of additives are used by manufacturers in their tobacco products (cigarettes, cigars and pipe tobacco) and the number of additives used per tobacco product type incre
Metals in tobacco harmful to health Growing tobacco plants acquire metals from soil, fertilisers, and industrial pollution. Smoking liberates some of these metals from tobacco into smoke to be inhaled by the smoker and bystanders.
Half of the Dutch participate in sport weekly In 2014, 53% of people between the ages of 12 and 80 in the Netherlands participate in some type of sport weekly.
Translation Dutch Health Care Performance Report 2014 available Every four years, RIVM assesses the quality, accessibility and affordability of the Dutch healthcare system.